DO-BO

The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff (Repost)

This is a repost of a popular episode of MAP – Market Access Podcast, from December 1st 2023.

We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO Dr. Stefan Walzer and the esteemed healthcare reimbursement expert, Ron de Graaff. 

Ron, with his deep-rooted experience starting from 1978, shares his invaluable insights on the evolution of healthcare reimbursement, a journey from simpler times to today’s intricate landscape involving multiple stakeholders like health insurance companies.

🔍 Key Highlights:

– Ron’s path from founding his company in 1985, which has since assisted over 900 entities, including governments, in understanding medical technology markets.

– Challenges faced by startups in healthcare, often led by technical experts who struggle with the language and complexities of reimbursement processes.

– The criticality of startups understanding both the payer perspectives and the changing requirements of reimbursement systems across Europe.

– Ron’s advice to startups: comprehensively understand the reimbursement system of your target market and assess if your product is likely to be reimbursable.

This episode is a must-listen for anyone in the healthcare industry, particularly startups navigating the daunting world of reimbursement. Expect to gain a thorough understanding of how to strategically plan for reimbursement, the importance of being updated with current regulations, and how to choose the right market for your product.

Related

In the latest Market Access Podcast episode, host Stefan Walzer sits down with Bernard “Bernie” Bichsel – one of Europe’s most experienced voices in medtech regulation and former Head of the Medical Devices Division at Swissmedic – to unpack how regulation and market access truly fit together. They discuss why medical device regulation in Europe […]

In this episode, Stefan Walzer talks with experienced Market Access manager Helmut Butscher about concrete AI applications across the full Market Access value chain. They explore how AI accelerates systematic literature reviews, unlocks real‑world evidence from complex data sources, supports HTA dossier preparation, and enables smarter decisions on pricing, reimbursement and global launch sequencing. They […]

In this thought‑provoking Market Access Podcast episode, host Stefan Walzer sits down with Omar Ali – Head of Payers at Vipora, former NICE advisor, and one of the sharpest minds in drug pricing and innovative contracting to unpack where drug pricing and reimbursement are really heading.  They explore why cost‑effectiveness thresholds are making market access […]